Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 2, 2014, Pages 236-245

  Lahoti, Tejas S ^a   Hughes, Jarod M ^a   Kusnadi, Ann ^a   John, Kaarthik ^b   Zhu, Bokai ^a   Murray, Iain A ^a   Gowda, Krishne ^c   Peters, Jeffrey M ^a   Amin, Shantu G ^c   Perdew, Gary H ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b DUPONT COMPANY   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; ANTIINFLAMMATORY AGENT; AROMATIC HYDROCARBON RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; EPIREGULIN; GELATINASE A; GELATINASE B; GNF 351; N [2 (3H INDOL 3 YL)ETHYL] 9 ISOPROPYL 2 (5 METHYL 3 PYRIDYL)PURIN 6 AMINE; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; JOINT DESTRUCTION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 84893052989     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.209726     Document Type: Article

References (49)

1. Afuwape AO, Kiriakidis S, and Paleolog EM (2002) The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 17:961-972.
2. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, and Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576-1587.
3. Baka Z, Buzás E, and Nagy G (2009) Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 11:238.
4. Bartok B and Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233:233-255.
5. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, and DenisonMS, et al. (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329:1345-1348.
6. Cha HS, Rosengren S, Boyle DL, and Firestein GS (2006) PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum 54:587-592.
7. Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, Sartor MA, and Puga A (2007) Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 27:6127-6139.
8. Choi SS, Miller MA, and Harper PA (2006) In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter. Toxicol Sci 94:163-174.
9. Cope AP (2008) T cells in rheumatoid arthritis. Arthritis Res Ther 10 (Suppl 1):S1.
10. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, and Perdew GH (2010a) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 115:89-97.
11. Dinatale BC and Perdew GH (2010) Protein function analysis: rapid, cell-based siRNA-mediated ablation of endogenous expression with simultaneous ectopic replacement. Cytotechnology 62:95-100.
12. DiNatale BC, Schroeder JC, Francey LJ, Kusnadi A, and Perdew GH (2010b) Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling. J Biol Chem 285:24388-24397.
13. DiNatale BC, Schroeder JC, and Perdew GH (2011) Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. Mol Carcinog 50:173-183.
14. DiNatale BC, Smith K, John K, Krishnegowda G, Amin SG, and Perdew GH (2012) Ah receptor antagonism represses head and neck tumor cell aggressive phenotype. Mol Cancer Res 10:1369-1379.
15. Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 39:1781-1790.
16. García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM, and Díaz-González F (2004) CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblastlike synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 50:3866-3877.
17. Giannelli G, Erriquez R, Iannone F, Marinosci F, Lapadula G, and Antonaci S (2004) MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumatol 22:335-338.
18. Hillegass JM, Murphy KA, Villano CM, and White LA (2006) The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease. Biol Chem 387:1159-1173.
19. Hutchinson D and Moots R (2001) Cigarette smoking and severity of rheumatoid arthritis. Rheumatology (Oxford) 40:1426-1427.
20. Ishida M, Mikami S, Kikuchi E, Kosaka T, Miyajima A, Nakagawa K, Mukai M, Okada Y, and Oya M (2010) Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Carcinogenesis 31:287-295.
21. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, and Suzuki R (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169:2643-2647.
22. John K, Lahoti TS, Wagner K, Hughes JM, and Perdew GH (2013) The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines. Mol Carcinog. DOI: 10.1002/mc.22032 [published ahead of print].
23. Koch AE (2000) The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59 (Suppl 1):i65-i71.
24. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, and Morand E (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48:103-109.
25. Lahoti TS, John K, Hughes JM, Kusnadi A, Murray IA, Krishnegowda G, Amin S, and Perdew GH (2013) Aryl hydrocarbon receptor antagonism mitigates cytokinemediated inflammatory signalling in primary human fibroblast-like synoviocytes. Ann Rheum Dis 72:1708-1716.
26. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, and Kim HY (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321-324.
27. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, David JR, Bucala R, and Morand EF (2003) Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 48:1881-1889.
28. Malemud CJ (2007) Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta 375:10-19.
29. Marshall NB and Kerkvliet NI (2010) Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann N Y Acad Sci 1183:25-37.
30. Martey CA, Baglole CJ, Gasiewicz TA, Sime PJ, and Phipps RP (2005) The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 289:L391-L399.
31. Martinez JM, Afshari CA, Bushel PR, Masuda A, Takahashi T, and Walker NJ (2002) Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p- dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol Sci 69:409-423.
32. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, and Gay S (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149:1607-1615.
33. Murphy G and Nagase H (2008) Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol 4:128-135.
34. Nah SS, Won HJ, Ha E, Kang I, Cho HY, Hur SJ, Lee SH, and Baik HH (2010) Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int 30:443-449.
35. Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, and Nishimoto N (2003) Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 48:1521-1529.
36. Onozaki K (2009) Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm Allergy Drug Targets 8:364-368.
37. Patel RD, Kim DJ, Peters JM, and Perdew GH (2006) The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci 89:75-82.
38. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, and Rosenbaum JT (1994a) Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 37:212-220.
39. Qu Z, Picou M, Dang TT, Angell E, Planck SR, Hart CE, and Rosenbaum JT (1994b) Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat. Am J Pathol 145:1127-1139.
40. Roman AC, Carvajal-Gonzalez JM, Rico-Leo EM, and Fernandez-Salguero PM (2009) Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGFA depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. J Biol Chem 284:25135-25148.
41. Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, Lin JM, Strom SC, Omiecinski CJ, and Amin S, et al. (2010) The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 49:393-400.
42. Shimba S, Komiyama K, Moro I, and Tezuka M (2002) Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells. J Biochem 132:795-802.
43. Smith KJ, Murray IA, Tanos R, Tellew J, Boitano AE, Bisson WH, Kolluri SK, Cooke MP, and Perdew GH (2011) Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J Pharmacol Exp Ther 338:318-327.
44. Takeuchi A, Takeuchi M, Oikawa K, Sonoda KH, Usui Y, Okunuki Y, Takeda A, Oshima Y, Yoshida K, and Usui M, et al. (2009) Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization. Invest Ophthalmol Vis Sci 50:3410-3416.
45. Villano CM, Murphy KA, Akintobi A, and White LA (2006) 2,3,7,8-Tetrachlorodibenzo-pdioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 210:212-224.
46. Yamane S, Ishida S, Hanamoto Y, Kumagai K, Masuda R, Tanaka K, Shiobara N, Yamane N, Mori T, and Juji T, et al. (2008) Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients. J Inflamm (Lond) 5:5.
47. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, and Okada Y (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455-461.
48. Zhao B, Degroot DE, Hayashi A, He G, and Denison MS (2010) CH223191 is a ligandselective antagonist of the Ah (Dioxin) receptor. Toxicol Sci 117:393-403.
49. Zvaifler NJ and Firestein GS (1994) Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789.